Review of allelic loss and gain in prostate cancer

World Journal of Urology

Volumn 14, Issue 5, 1996, Pages 338-346

  Bova, G S ^a   Isaacs, W B ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ALLELE; GENE LIBRARY; GENETICS; HUMAN; MALE; ONCOGENE; PROSTATE TUMOR; REVIEW; SOUTHERN BLOTTING;

ALLELES; BLOTTING, SOUTHERN; DNA, NEOPLASM; GENOMIC LIBRARY; HUMANS; MALE; ONCOGENES; PROSTATIC NEOPLASMS;

EID: 0030342130     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00184607     Document Type: Article

References (79)

1. Alcaraz A, Takahashi S, Brown JA, Herath JF, Bergstralh EJ, Larson-Keller JJ, Lieber MM, Jenkins RB (1994) Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res 54:3998-4002
2. Aly MS, Cin PD, Van de Voorde W, Poppel H van, Ameye F, Baert L, Van den Berghe H (1994) Chromosome abnormalities in benign prostatic hyperplasia. Genes Chromosome Cancer 9 : 227-233
3. Arps S, Rodewald A, Schmalenberger B, Carl P, Bressel M, Kastendieck H (1993) Cytogenetic survey of 32 cancers of the prostate. Cancer Genet Cytogenet 66:93-99
4. Atkin NB, Baker MC (1985) Chromosome study of five cancers of the prostate. Hum Genet 70:359-364
5. Bandyk MG, Zhao L, Troncoso P, Pisters LL, Palmer JL, Eschenbach AC von, Chung LWK, Liang JC, Chung LW (1994) Trisomy 7: a potential cytogenetic marker of human prostate cancer progression. Genes Chromosomes Cancer 9:19-27
6. Bardi G, Johansson B, Pandis N, Heim S, Mandahl N, Hagerstrand I, Holmin T, Andren-Sandberg A, Mitelman F (1992) Trisomy 7 in nonneoplastic focal steatosis of the liver. Cancer Genet Cytogenet 63:22-24
7. Beige G, Thode B, Rippe V, Bartnitzke S, Bullerdiek J (1994) A characteristic sequence of trisomies starting with trisomy 7 in benign thyroid tumors. Hum Genet 94:198-202
8. Bergerheim US, Kunimi K, Collins VP, Ekman P (1991) Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chromosomes Cancer 3:215-220
9. Bova GS, Carter BS, Bussemakers MJ, Emi M, Fujiwara Y, Kyprianou N, Jacobs SC, Robinson JC, Epstein JI, Walsh PC, et al (1993) Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 53:3869-3873
10. Bova GS, MacGrogan D, Levy A, Pin SS, Bookstein R, Isaacs WB (1996) Physical mapping of chromosome 8p22 markers and their homozygous deletion in a metastatic prostate cancer. Genomics 35:46-54
11. Brewster SF, Browne S, Brown K W (1994) Somatic allelic loss at the DCC, APC, nm23-Hl, and p53 tumor suppressor gene loci in human prostatic carcinoma. J Urol 151: 1073-1077
12. Brooks JD, Bova GS, Ewing CM, Epstein JL, Carter BS, Piantadosi S, Robinson JC, Isaacs WB (1996) An uncertain role for p53 alterations in human prostate cancers. Cancer Res (in press)
13. Brothman AR, Peehl DM, Patel AM, McNeal JE (1990) Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Res 50:3795-3803
14. Brothman AR, Steele MR, Williams BJ. Jones E. Odelberg S. Albertsen HM, Jorde LB, Rohr LR, Stephenson RA (1995) Loss of chromosome 17 loci in prostate cancer detected by polymerase chain reaction quantitation of atlelelic markers. Genes Chromosomes Cancer 13:278-284
15. Bullerdiek J, Leuschner E, Taquia E, Bonk U, Bartnitzke S (1993) Trisomy 8 as a recurrent clonal abnormality in breast cancer? Cancer Genet Cytogenet 65:64-67
16. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A. Mao L, Herath J, Jenkins R, Westra W, et al (1995) Frequency of homozygous deletion at p!6/CDKN2 in primary human tumors. Nature Genet 11 :210-212
17. Carter BS, Ewing CM, Ward WS, Treiger BF. Aalders TW. Schalken JA, Epstein JI, Isaacs WB (1990) Allelic loss of chromosomes 16q and lOq in human prostate cancer. Proc Natl Acad Sei USA 87:8751-8755
18. Casalone R, Granata P, Minelli E, Portentoso P, Giudici A, Righi R, Castelli P, Socrate A, Frigerio B (1991) Cytogenetic analysis reveals clonal proliferation of smooth muscle cells in atherosclerotic plaques. Hum Genet 87:139-143
19. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH (1996) Genetic alterations in untreated prostate cancer métastases and androgen independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 56:3091-3102
20. Cher ML, Ito T, Weidner N, Carroll PR, Jensen RH (1995) Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH). J Urol 153:249-254
21. Cher ML, MacGrogan D, Bookstein R, Brown JA, Jenkins RB, Jensen RH (1994) Comparative genomic hybridization, allelic imbalance, and fluoresence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosomes Cancer 11 : 153-162
22. Cliby W, Ritland S, Hartmann L, Dodson M, Hailing KC, Keeney G, Podratz KC, Jenkins RB (1993) Human epithelial ovarian cancer allelotype. Cancer Res 53:2393-2398
23. Cunningham C, Dunlop MG, Wyllie AH, Bird CC (1993) Deletion mapping in colorectal cancer of a putative tumour suppressor gene in 8p22-p21.3. Oncogene 8:1391-1396
24. Dal Cin P, Aly MS, Delabie J, Ceuppens JL, Van Gool S, Van Damme B, Baert L, Poppel H van, Van den Berghe H (1992) Trisomy 7 and trisomy 10 characterize subpopulations of tumor-infiltrating lymphocytes in kidney tumors and in the surrounding kidney tissue. Proc Natl Acad Sei USA 89:97449748
25. Davis LM, Zabel B, Senger G, Ludecke HJ, Metzroth B, Call K, Housman D, Claussen U, Horsthemke B, Shows TB (1991) A tumor chromosome rearrangement further defines the 11 p 13 Wilms tumor locus. Genomics 10:588-592
26. Eagle L, Yin X, Brothman A, Williams BJ, Atkin N, Prochownik E (1995) Mutation of the MXI1 gene in prostate cancer. Nature Genet 9:249-255
27. Emi M, Fujiwara Y, Nakajima T, Tsuchiya E, Tsuda H, Hirohashi S, Maeda Y, Tsuruta K, Miyaki M, Nakamura Y (1992) Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carinoma, colorectal cancer, and lung cancer. Cancer Res 52:5368-5372
28. Emmert-Buck MR, Vocke CD, Pozzatti RO, Duray PH, Jennings SB, Florence CD, Zhuang Z, Bostwick DG, Liotta LA, Linehan WM (1995) Allelic loss on chromosome 8pl2-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res 55:2959-2962
29. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP (1986) A human DNA segment with properties of the gene that predisposes retinoblastoma and osteosarcoma. Nature 323:643-646
30. Fujiwara Y, Emi M, Ohata H, Kato Y, Nakajima T, Mori T, Nakamura Y (1993) Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma. Cancer Res 53:1172-1174
31. Fujiwara Y, Monden M, Mori T, Nakamura Y, Emi M (1993) Fréquent multiplication of the long arm of chromosome 8 in heptaocellular carcinoma. Cancer Res 53:857-860
32. Fujiwara Y, Ohata H, Emi M, Okui K, Koyama K, Tsuchiya E, Nakajima T, Monden M, Mori T, Kurimasa A, Oshimura M, Nakamura Y (1994) A 3-Mb physical map of the chromosome region 8p21.3-p22, including a 600-kb region commonly deleted in human hepatocellular carcinoma, colorectal cancer, and nonsmall cell lung cancer. Genes Chromosomes Cancer 10:7-14
33. Fung YK, Murphree AL. TAng A, Qian J, Hinrichs SH, Benedict WF (1987) Structural evidence for the authenticity of the human retinoblastoma gene. Science 236: 1657-1661
34. Gray IC, Phillips SMA, Lee SJ, Neoptolemos JP, Weissenbach J, Spurr NK (1995) Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res 55:4800-4803
35. Herbergs J, Bruine AP de. Marx PT, Vallinga MI, Stockbrugger RW, Ramaekers FC, Arends JW, Hopman AH (1994) Chromosome aberrations in adenomas of the colon. Proof of trisomy 7 in tumor cells by combined interphase cytogenetics and immunocytochemistry. Int J Cancer 57:781-785
36. Ichikawa T, Nihei N, Suzuki H, Oshimura M, Emi M, Nakamura Y, Hayata I, Isaacs JT, Shimazaki J (1994) Suppression of metastasis of rat prostatic cancer by introducing human chromosome 8. Cancer Res 54:2299-2302
37. Ittman M (1996) Allelic loss on chromosome 10 in prostate adenocarcinoma. Cancer Res 56:2143-2147
38. Jarrard DF. Bova GS, Ewing CM, Herman JG, Pin SS, Nguyen SH, Cairns P, Sidransky D, Baylin SB, Isaacs WB (1996) Deletional, mutational. and methylation analyses of p!6/CDKN2/ MTS1 in primary and metastatic prostate cancer. Cancer Research (in press)
39. Johansson B, Heim S, Mandahl N, Mertens F, Mitelman F (1993) Trisomy 7 in nonneoplastic cells (review). Genes Chromosomes Cancer 6:199-205
40. Joos S. Bergerheim USR, Pan Y, Matsuyama H, Bentz M, Dumanoir S. Lichter P (1995) Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization. Genes Chromosomes Cancer 14:267-276
41. Kallioniemi A, Kallioniemi OP, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM (1994) Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sei USA 91 :2156-2160
42. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stocken E, Day RS, Johnson BE, Skolnick MH
43. (1994) A cell cycle regulator potentially involved in genesis of many tumor types [see commentsJ. Science 264:436-440
44. Kerangueven F. Essioux L, Dib A, Noguchi T, Allione F, Geneix J, Longy M, Lidereau R, Eisinger F, Pebusque MJ, et al (1995) Loss of heterozygosity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8. Oncogene 10:1023-1026
45. Knowles MA, Shaw ME, Proctor AJ (1993) Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms. Oncogene 8: 1357-1364
46. Knuutila S, Larramendy ML, Elfving P, el-Rifai W, Miettinen A, Mitelman F (1995) Trisomy 7 in non-neoplastic tubular epithelial cells of the kidney. Hum Genet 95:149-156
47. Konig JJ, Kamst E, Hagemeijer A, Romijn JC, Horoszewicz J, Schröder FH (1989) Cytogenetic characterization of several androgen responsive and unresponsive sublines of the human prostatic carcinoma cell line LNCaP. Urol Res 17:79-86
48. Latil A, Baron JC, Cussenot O, Fournier G, Soussi T, BocconGibod L. Le Duc A, Rouesse J, Lidereau R (1994) Genetic alterations in localized prostate cancer: identification of a common region of deletion on chromosome arm 18q. Genes Chromosomes Cancer 11 : 119-125
49. Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, Lee EY (1987) Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235: 1394-1399
50. Lundgren R, Mandahl N, Heim S, Limon J, Henrikson H, Mitelman F (1992) Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Gènes Chromosomes Cancer 4:16-24
51. MacGrogan D, Levy A, Bostwick D, Wagner M, Wells D. Bookstein R (1994) Loss of chromosome arm 8p in loci in prostate cancer: mapping by quantitative allelic imbalance. Genes Chromosomes Cancer 10:151-159
52. MacGrogan D, Levy A, Bova GS, Isaacs WB, Bookstein R (1996) Structure and methylation-associated silencing of a gene within a homozygously deleted region on human chromosome band 8p22. Genomics (in press)
53. Macoska JA, Micale MA, Sakr WA, Benson PD, Wolman SR (1993) Extensive genetic alterations in prostate cancer revealed by dual PCR and FISH analysis. Genes Chromosomes Cancer 8:88-97
54. Macoska JA, Trybus TM, Benson PD, Sakr WA, Grignon DJ, Wojno KD, Pietruk T, Powell IJ (1995) Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer. Cancer Res 55:5390-5395
55. Macoska JA, Trybus TM, Sakr WA, Wolf MC, Benson PD, Powell IJ, Pontes JE (1994) Fluorescence in situ hybridization analysis of 8p allelic loss and chromosme 8 instability in human prostate cancer. Cancer Res 54:3824-3830
56. Massenkeil G, Oberhuber H, Hailemariam S, Sulser T, Diener PA, Bannwart F, Schafer R, Schwarte-Waldhoff I (1994) P53 mutations and loss of heterozygosity on chromosomes 8p, 16q, 17p, and 18q are confined to advanced prostate cancer. Anticancer Res 14:2785-2790
57. Matsuyama H, Bergerheim US, Nilsson I, Pan Y. Skoog L, Tribukait B, Ekman P (1994) Nonrandom numerical aberrations of chromosomes 7, 9, and 10 in DNA-diploid bladder cancer. Cancer Genet Cytogenet 77: 118-124
58. Matsuyama H, Pan Y, Skoog L, Tribukait B, Naito K, Ekman P, Lichter P, Bergerheim US (1994) Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization. Oncogene 9:3071-3076
59. Micale MA, Sanford JS, Powell IJ, Sakr WA, Wolman SR (1993) Defining the extent and nature of cytogenetic events in prostatic adenocarcinoma: paraffin FISH vs. metaphase analysis. Cancer Genet Cytogenet 69:7-12
60. Ohata H, Emi M, Fujiwara Y, Higashino K, Nakagawa K, Futagami R, Tsuchiya E, Nakamura Y (1993) Deletion mapping of the short arm of chromosome 8 in non-small cell lung carcinoma. Genes Chromosomes Cancer 7:85-88
61. Pykett MJ, Murphy ME, Harnish PR, Muenke M, Marks J, George DL (1994) Loss of chromosome 8p sequences in human breast carcinoma cell lines. Cancer Genet Cytogenet 76: 23-28
62. ol.Qian JQ, Bostwick DG, Takahashi S, Borell TJ, Herath JF, Lieber MM, Jenkins RB (1995) Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res 55:5408-5414
63. Sakr WA, Macoska JA, Benson P, Grignon DJ, Wolman SR, Pontes JE, Crissman JD (1994) Allelic loss in locally metastatic, multisampled prostate cancer. Cancer Res 54:32733277
64. Shibagaki I, Shimada Y, Wagata T, Ikenaga M, Imamura M, Ishizaki K (1994) Allelotype analysis of esophageal squamous cell carcinoma. Cancer Res 54:2996-3000
65. Suzuki H, Emi M, Komiya A, Fujiwara Y, Yatani R, Nakamura Y, Shimazaki J (1995) Localization of a tumor suppressor gene associated with progression of human prostate cancer within a 1.2 Mb region of 8p22-p21.3. Genes Chromsomes Cancer 13:168-174
66. Takahashi S, Qian J, Brown JA, Alcaraz A, Bostwick DG, Lieber MM, Jenkins RB (1994) Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. Cancer Res 54:3574-3579
67. Takahashi S, Shan AL, Ritland SR, Delacey KA, Bostwick DG, Lieber MM, Thibodeau SN, Jenkins RB (1995) Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. Cancer Res 55:4114-4119
68. Trapman J, Sleddens HF, Weiden MM van der, Dinjens WN. Konig JJ, Schröder FH. Faber PW. Bosnian FT (1994) Loss of helerozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Cancer Res 54:60616064
69. Trybus TM, Burgess AC. Wojno KJ. Glover TW. Macoska JA (1996) Distinct areas of allelic loss on chromosomal regions 10p and lOq in human prostate cancer. Cancer Res 56:22632267
70. Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HF, Schaafsma HE, Debruyne FM, Isaacs WB (1992) Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 52:5104-5109
71. Van den Berg C, Guan XY, Von Hoff D, Jenkins R, Bittner M, Griffin C, Kallioniemi O, Visakorpi T, McGill J, Herath J, Epstein J, Sarosdy M, Meltzer P, Trent J (1995) DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic implications. Clin Cancer Res 1:11-18
72. Visakorpi T, Kallioniemi A, Syvanen AC, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi OP ( 1995) Geneticchanges in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55:342-347
73. Wasylyshyn ML, Neuman WL, Angriman I, Snyder LA, Montag AG, Westbrook ÇA, Michelassi F (1991) Evidence for a new tumor-suppressor gene involved in gastrointestinal malignancies. Surgery I 10:265-268: discussion 268-269
74. Watson DL. Mashal R, Krithivas K. Corless C. KunlolT P. Richie JP, Sklur J (1995) Loss of heteroJ.ygosity at chromosomal locus 7q21-q31 in metastatic prostate cancer (abstract). J Urol 153:271A
75. Walt AJ, Devereux FJ. Monk NA, Myers CM, Gardner RJ ( 1991 ) The phenotype in placental trisomy 7. Aust NZJ Obstet Gynaecol 31 :246-248
76. Williams BJ. Jones E, Zhu XL, Steele MR, Stephenson RA. Rohr RL, Brothman AR (1996) Evidence for a tumor suppressor gene distal to BRCA1 in prostate cancer. J Urol 155:720-725
77. Yaremko ML. Wasylyshyn ML, Paulus KL. Michelassi F. Westbrook ÇA (1994) Deletion mapping reveals two regions on chromosome 8 allele loss in colorectal carcinomas. Genes Chromsomes Cancer 10: 1-6
78. Zenklusen JC, Thompson JC, Troneoso P, Kagan J, Conti CJ ( 1994) Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1. Cancer Res 54:6370-6373
79. Zitzelsberger H, Szucs S, Weier HU, Lehmann L, Braselmann H, Enders S, Schilling A, Breul J, Hofier H. Bauchinger M (1994) Numerical abnormalities of chromosome 7 in human prostate cancer detected by fluorescence in situ hybridization (FISH) on paraffin-embedded tissue sections with centromerespecific DNA probes. J Pathol 172:325-335